Vaccines for allergy.

Abstract

Vaccines aim to establish or strengthen immune responses but are also effective for the treatment of allergy. The latter is surprising because allergy represents a hyper-immune response based on immunoglobulin E production against harmless environmental antigens, i.e., allergens. Nevertheless, vaccination with allergens, termed allergen-specific immunotherapy is the only disease-modifying therapy of allergy with long-lasting effects. New forms of allergy diagnosis and allergy vaccines based on recombinant allergen-derivatives, peptides and allergen genes have emerged through molecular allergen characterization. The molecular allergy vaccines allow sophisticated targeting of the immune system and may eliminate side effects which so far have limited the use of traditional allergen extract-based vaccines. Successful clinical trials performed with the new vaccines indicate that broad allergy vaccination is on the horizon and may help to control the allergy pandemic.

• Authors: Birgit Linhart, Rudolf Valenta
• Journal: Current opinion in immunology (Curr Opin Immunol) Vol. 24 Issue 3 Pg. 354-60 (Jun 2012) ISSN: 1879-0372 [Electronic] England
• PMID: 22521141 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: Copyright © 2012 Elsevier Ltd. All rights reserved.

Chemical References

• Allergens
• Vaccines

Topics

• Allergens (immunology)
• Animals
• Clinical Trials as Topic
• Humans
• Hypersensitivity (immunology, prevention & control)
• Immunotherapy
• Vaccines (immunology)